Vimarsana
Biggest News Aggregation in the World

Page 2 - Intersect Ent Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersect Ent Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersect Ent Inc Today - Breaking & Trending Today

Nasal Polyps Market Opportunities, Top Manufactures, Industry Growth, Share, Size, Analysis and Global Forecast to 2030 - Vimarsana News

Nasal Polyps Market Opportunities, Top Manufactures, Industry Growth, Share, Size, Analysis and Global Forecast to 2030

A novel report on global Nasal Polyps market has been recently published by Reports and Data that offers a comprehensive

Intersect ENT (NASDAQ:XENT) Coverage Initiated at StockNews.com - Vimarsana News

Intersect ENT (NASDAQ:XENT) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Intersect ENT Price Performance XENT stock opened at $28.24 on Wednesday. The firm has a market cap of […]

Sinus Dilation Devices Market worth $3.8 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Sinus Dilation Devices Market worth $3.8 billion by 2027 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- Sinus Dilation Devices Market is projected to grow from USD 2.8 billion in 2022 to USD 3.8 billion by 2027, at a CAGR of 6.6% from 2022 to...

Global Antitrust and Competition Law Update Newsletter - Vimarsana News

Global Antitrust and Competition Law Update Newsletter

The FTC issued two orders for public comment in June 2022 settling allegations that JAB Consumer Partners’ $1.1 billion acquisition of SAGE Veterinary Partners and $1.65 billion acquisition of the parent of veterinary clinic owner Ethos violated federal antitrust laws.

FTC Issues Final Order Settling Charges Against Medtronic for Acquisition of Ear, Nose and Throat Competitor - Vimarsana News

FTC Issues Final Order Settling Charges Against Medtronic for Acquisition of Ear, Nose and Throat Competitor

On June 30, the FTC approved a final order settling charges against Medtronic, Inc. for its acquisition of Intersect ENT, Inc. with the intent to protect